Resource library Whare rauemi

The Health Quality & Safety Commission, Choosing Wisely and the Australian and New Zealand College of Anaesthetists have developed an information leaflet to help patients, caregivers and whānau use opioid medicines safely, to manage non-cancer pain.

Guidelines for the display of combination product medicines in electronic systems.

Tools developed by Waitematā DHB to encourage the safer prescribing and the best practice use of oxygen therapy, to reduce harm to patients.

Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3

New dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.

Northland District Health Board (DHB), in conjunction with the regional Child Health Network and Whakawhetu, has produced four television commercials promoting SUDI prevention with the acronym PEPE - Place, Eliminate, Position and Encourage.

This report sets out the work of the Family Violence Death Review Committee (FVDRC) from January 2013 to December 2013.

This report details perinatal and maternal deaths from 1 January to 31 December 2012, and analyses six years of perinatal mortality data from 2007 to 2012 and seven years of maternal mortality data from 2006 to 2012.

This report sets out the work of the Family Violence Death Review Committee (FVDRC) from December 2011 to December 2012.

This is the seventh annual report of the Perinatal and Maternal Mortality Review Committee (PMMRC). The aim of this committee is to identify areas in maternity and newborn care where improvements could be made.